Viz ANEURYSM vs ContaCT

Direct competitors — feature-level head-to-head below. Comparability 95/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Viz.ai
VS
by Viz.AI

AI Verdict

Viz ANEURYSM is a specialized solution focused solely on the auto-detection and coordination of suspected cerebral aneurysms. ContaCT, while also from Viz.ai, is a broader AI-powered care coordination platform that includes aneurysm detection among its multiple disease detection capabilities, alongside more extensive workflow optimization and integration features. Therefore, Viz ANEURYSM is ideal for focused neurovascular care, whereas ContaCT offers a more comprehensive, multi-disease detection and workflow management system.

Choose Viz ANEURYSM if…

Choose Viz ANEURYSM if your primary objective is to specifically enhance the detection and management of suspected cerebral aneurysms. This tool excels at providing rapid, AI-powered identification of aneurysms in CTAs, coupled with specialized 3D imaging and direct care team coordination for neurovascular cases. It is ideal for optimizing workflows solely focused on improving outcomes for aneurysm patients.

View Viz ANEURYSM →

Choose ContaCT if…

Choose ContaCT if your organization requires a comprehensive AI-powered platform for accelerating disease detection and care coordination across multiple acute conditions, including stroke, pulmonary embolism, and hypertrophic cardiomyopathy, in addition to aneurysms. This solution offers a broader suite of features like real-time alerts, secure mobile communication, and deep integration with existing hospital IT infrastructure (PACS/EHR) to optimize workflows for a wider range of emergent cases.

View ContaCT →

When choosing between Viz ANEURYSM and ContaCT, physicians should consider their primary focus and workflow needs. Viz ANEURYSM is specifically designed for the auto-detection of suspected cerebral aneurysms in CT angiograms (CTAs), offering AI-enhanced 3D imaging and interactive tools for neurovascular assessment. It excels at streamlining the management of aneurysm patients through real-time notifications and one-click referral activation, making it ideal for practices with a dedicated focus on neurovascular care and aneurysm detection.

In contrast, ContaCT is a broader AI-powered care coordination platform with multiple FDA clearances, encompassing the detection of various acute conditions such as large vessel occlusion (LVO) stroke, intracranial hemorrhage (ICH), hypertrophic cardiomyopathy (HCM), pulmonary embolism (PE), and aneurysms. Its key practical difference lies in its comprehensive disease detection capabilities and robust care coordination features, including automated chart summarization and guideline-based recommendations. Physicians seeking a more expansive AI platform for accelerating disease detection and optimizing workflows across multiple acute conditions, particularly in emergency medicine, neurology, and radiology, would find ContaCT more suitable.

Therefore, a neurovascular specialist primarily concerned with efficient aneurysm detection and management would likely benefit most from Viz ANEURYSM. Conversely, a physician or hospital system aiming to enhance care coordination and accelerate detection for a wider range of acute neurological and cardiovascular conditions should opt for ContaCT due to its broader scope and integrated workflow optimization features.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Viz ANEURYSM ContaCT
Pricing Contact for pricing Subscription-based
Deployment Cloud-based; Standalone application; Mobile software module Cloud-based, integrates with existing hospital IT infrastructure (PACS, EHR).
FDA Status 1 AI-estimated 1 AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Viz ANEURYSM ContaCT
Name Viz ANEURYSM ContaCT
Company Viz.ai Viz.AI
Description Viz ANEURYSM is an FDA-cleared AI-powered solution by Viz.ai that auto-detects suspected cerebral aneurysms in CT angiograms (CTAs), streamlining neurovascular care coordination and facilitating timely patient management. Viz.ai is a pioneering AI-powered care coordination platform that accelerates disease detection and streamlines clinical workflows. With multiple FDA clearances, including the initial Viz.AI Contact application for stroke, it helps ensure patients receive timely treatment across over 1,700 hospitals globally.
Key Features Auto-detection of suspected cerebral aneurysms in CTAs; AI-enhanced 3D imaging (Viz 3D CTA); Interactive tools for neurovascular assessment; Streamlined workflow and automated 3D processing; Real-time notification to appropriate care providers; HIPAA-compliant secure messaging for care team coordination; One-click referral activation for follow-up; High sensitivity and specificity for aneurysm detection (e.g., u2265 4mm aneurysms) AI-powered disease detection (LVO, ICH, HCM, PE, Aneurysm); Real-time AI-powered alerts and notifications; Mobile application for specialists to view images and communicate; Secure, HIPAA-compliant group communication messaging; Integration with PACS and EHR systems; High-fidelity 3D web and mobile image viewer; Automated chart summarization; Guideline-based recommendations
Specialties Neurology, Neurosurgery, Radiology Emergency Medicine, Neurology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Viz ANEURYSM and ContaCT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Viz ANEURYSM is an AI-powered solution specifically designed for the auto-detection of suspected cerebral aneurysms in CT angiograms. ContaCT is a broader AI-powered care coordination platform that detects multiple diseases, including LVO, ICH, HCM, PE, and Aneurysm.
ContaCT explicitly states integration with existing hospital IT infrastructure, including PACS and EHR systems. Viz ANEURYSM is cloud-based and can function as a standalone application or mobile software module.
Yes, Viz ANEURYSM highlights specific features like AI-enhanced 3D imaging (Viz 3D CTA) and interactive tools for neurovascular assessment. It also specifies high sensitivity and specificity for aneurysm detection (e.g., u2265 4mm aneurysms).
Beyond real-time alerts and secure communication common to both, ContaCT offers automated chart summarization and guideline-based recommendations to further streamline clinical workflows.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.